E
Neptune Wellness Solutions Inc. NEPT.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 8/1/2023Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to E- from E+ on 8/1/2023 due to a major decline in the solvency index. The quick ratio declined from 0.28 to 0.23.
E
Sell 3/14/2023Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell 2/23/2023Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D- from E+ on 02/23/2023.
E
Sell 2/8/2023Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
D
Sell 12/21/2022Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D- from D on 12/21/2022 due to a significant decline in the growth index and solvency index. Earnings per share declined from -$0.72 to -$3.9396, debt to equity increased from 0.29 to 1.33, and the quick ratio declined from 0.41 to 0.2.
D
Sell 8/18/2022Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D from D- on 8/18/2022 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from -$6.5692 to -$0.72, EBIT increased 52.57% from -$28.81M to -$13.66M, and total revenue increased 41.45% from $11.5M to $16.27M.
D
Sell 7/11/2022Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D- from D on 7/11/2022 due to a major decline in the growth index, solvency index and volatility index. EBIT declined 168.68% from -$10.72M to -$28.81M, earnings per share declined from -$3.0972 to -$6.5692, and debt to equity increased from 0.15 to 0.26.
D
Sell 6/13/2022Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D from D- on 6/13/2022 due to a large increase in the growth index. Operating cash flow increased 31.55% from -$14.19M to -$9.72M, EBIT increased 30.2% from -$15.36M to -$10.72M, and total revenue increased 17.24% from $12.49M to $14.64M.
D
Sell 5/5/2022Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D- from E+ on 05/05/2022.
E
Sell 4/20/2022Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to E+ from D- on 4/20/2022 due to a decline in the growth index, volatility index and total return index.
D
Sell 11/16/2021Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D- from E+ on 11/16/2021.
E
Sell 11/8/2021Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to E+ from D- on 11/8/2021 due to a decline in the total return index and volatility index.
D
Sell 10/11/2021Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D- from D on 10/11/2021 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.81 to 2.03, and debt to equity increased from 0.1 to 0.11.
D
Sell 7/16/2021Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D from D- on 7/16/2021 due to an increase in the growth index and total return index. Operating cash flow increased 29.51% from -$14.28M to -$10.07M, earnings per share increased from -$0.4504 to -$0.3271, and total revenue increased 10.28% from $2.55M to $2.81M.
D
Sell 7/14/2021Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D- from D on 7/14/2021 due to a decline in the volatility index.
D
Sell 6/25/2021Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D from D- on 6/25/2021 due to an increase in the volatility index.
D
Sell 5/18/2021Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D- from D on 5/18/2021 due to a decline in the total return index and volatility index.
D
Sell 3/4/2021Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D from D- on 3/4/2021 due to an increase in the valuation index.
D
Sell 2/17/2021Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D- from D on 2/17/2021 due to a significant decline in the total return index, efficiency index and volatility index. Net income declined 245.31% from -$16.39M to -$56.61M, and total capital declined 19.52% from $120.55M to $97.02M.
D
Sell 10/3/2019Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D from D+ on 10/3/2019 due to a decline in the total return index.
D
Sell 9/18/2019Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to D+ from D on 9/18/2019 due to an increase in the total return index.
D
Sell 9/3/2019Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D from D+ on 9/3/2019 due to a major decline in the total return index.
D
Sell 8/15/2019Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D+ from C- on 8/15/2019 due to a noticeable decline in the growth index, efficiency index and solvency index. Operating cash flow declined 86.54% from -$2.47M to -$4.6M, EBIT declined 44.21% from -$3.31M to -$4.77M, and debt to equity increased from 0.05 to 0.07.
C
Hold 5/1/2019Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to C- from D+ on 5/1/2019 due to a major increase in the total return index.
D
Sell 12/31/2018Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to D+ from C- on 12/31/2018 due to a noticeable decline in the total return index, volatility index and solvency index.
C
Hold 11/19/2018Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to C- from C on 11/19/2018 due to a substantial decline in the total return index.
C
Hold 11/14/2018Downgrade
Neptune Wellness Solutions Inc. (NEPT.TO) was downgraded to C from C+ on 11/14/2018 due to a significant decline in the valuation index, efficiency index and growth index.
C
Hold 10/29/2018Upgraded
Neptune Wellness Solutions Inc. (NEPT.TO) was upgraded to C+ from C on 10/29/2018 due to a large increase in the total return index, valuation index and volatility index.
C
Hold 9/17/2018Downgrade
Neptune Technologies & Bioressources Inc. (NEPT.TO) was downgraded to C from C+ on 9/17/2018 due to a noticeable decline in the valuation index and total return index.
C
Hold 8/21/2018Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C+ from C on 8/21/2018 due to an increase in the total return index, growth index and volatility index. EBIT increased 34.13% from -$4.75M to -$3.13M, and earnings per share increased from -$0.0477 to -$0.0403.
C
Hold 7/6/2018Downgrade
Neptune Technologies & Bioressources Inc. (NEPT.TO) was downgraded to C from C+ on 7/6/2018 due to a noticeable decline in the total return index and valuation index.
C
Hold 6/21/2018Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C+ from C on 6/21/2018 due to a noticeable increase in the total return index, solvency index and volatility index.
C
Hold 6/6/2018Downgrade
Neptune Technologies & Bioressources Inc. (NEPT.TO) was downgraded to C from C+ on 6/6/2018 due to a noticeable decline in the total return index, valuation index and solvency index. The quick ratio declined from 3.27 to 2.6.
C
Hold 5/25/2018Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C+ from C on 5/25/2018 due to a noticeable increase in the total return index and volatility index.
C
Hold 5/1/2018Downgrade
Neptune Technologies & Bioressources Inc. (NEPT.TO) was downgraded to C from C+ on 5/1/2018 due to a noticeable decline in the total return index.
C
Hold 4/11/2018Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C+ from C on 4/11/2018 due to a large increase in the total return index.
C
Hold 3/14/2018Downgrade
Neptune Technologies & Bioressources Inc. (NEPT.TO) was downgraded to C from C+ on 3/14/2018 due to a decline in the total return index.
C
Hold 2/27/2018Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C+ from C on 2/27/2018 due to a significant increase in the total return index, solvency index and efficiency index. Debt to equity declined from 0.1 to 0.05, and the quick ratio increased from 3.27 to 3.27.
C
Hold 11/29/2017Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C from C- on 11/29/2017 due to an increase in the volatility index, total return index and solvency index.
C
Hold 11/21/2017Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to C- from D+ on 11/21/2017 due to an increase in the volatility index and total return index.
D
Sell 11/15/2017Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to D+ from D on 11/15/2017 due to a major increase in the valuation index, efficiency index and solvency index. Net income increased 1,424.15% from -$1.15M to $15.22M, the quick ratio increased from 1.37 to 3.27, and debt to equity declined from 0.35 to 0.1.
D
Sell 7/21/2017Downgrade
Neptune Technologies & Bioressources Inc. (NEPT.TO) was downgraded to D from D+ on 7/21/2017 due to a decline in the total return index and volatility index.
D
Sell 1/13/2017Upgraded
Neptune Technologies & Bioressources Inc. (NEPT.TO) was upgraded to D+ from D on 1/13/2017 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 977.81% from -$917.8 to $8.06M, earnings per share increased from -$0.0118 to $0.1034, and total capital increased 7.52% from $67.72M to $72.81M.
D
Sell 3/11/2016Downgrade
Neptune Technologies & Bioressources, Inc. (NTB.TO) was downgraded to D from D+ on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. The quick ratio declined from 2.85 to 2.35.
D
Sell 10/15/2015Upgraded
Neptune Technologies & Bioressources, Inc. (NTB.TO) was upgraded to D+ from D on 10/15/2015 due to a major increase in the growth index and efficiency index. Operating cash flow increased 63.72% from -$2.39M to -$3.91M, and total revenue increased 56.82% from $2.18M to $3.43M.
D
Sell 5/28/2015Downgrade
Neptune Technologies & Bioressources, Inc. (NTB.TO) was downgraded to D from D+ on 5/28/2015 due to a large decline in the growth index, efficiency index and solvency index. Operating cash flow declined 26.27% from -$7.95M to -$5.86M, debt to equity increased from 0.22 to 0.27, and total revenue declined 20.97% from $4.24M to $3.35M.
D
Sell 2/2/2015Upgraded
Neptune Technologies & Bioressources, Inc. (NTB.TO) was upgraded to D+ from D on 2/2/2015 due to an increase in the growth index. Total revenue increased 74.9% from $2.42M to $4.24M, and operating cash flow increased 8% from -$7.36M to -$7.95M.
D
Sell 9/29/2014Downgrade
Neptune Technologies & Bioressources, Inc. (NTB.TO) was downgraded to D from D+ on 9/29/2014 due to a decline in the volatility index.
D
Sell 9/11/2014Upgraded
Neptune Technologies & Bioressources, Inc. (NTB.TO) was upgraded to D+ from D on 9/11/2014 due to an increase in the volatility index and valuation index.
D
Sell 7/17/2014Downgrade
Neptune Technologies & Bioressources, Inc. (NTB.TO) was downgraded to D from D+ on 7/17/2014 due to a significant decline in the volatility index, total return index and growth index. Earnings per share declined from $0.0029 to -$0.0581, operating cash flow declined 139.02% from -$2.69M to $1.05M, and EBIT declined 17.07% from -$10.61M to -$8.8M.
Weiss Ratings